Allergan's Fourth Quarter Beats Earnings Forecasts

Allergan Inc. said Wednesday that fourth-quarter net income was $537.2 million, or $1.77 a share, compared with $312.9 million, or $1.04 a share, for the same period a year ago. Sales for the Irvine, Calif.-based drug maker were $1.91 billion against last year's $1.68 billion. Adjusted earnings were $2.17 a share, well ahead of the $1.83 forecast from analysts polled by FactSet. Revenue came in slightly ahead of the $1.9 billion view. Shares ended trading Wednesday down marginally to $219.42.